PPD uses cookies on this website. Please be aware that if you continue browsing the website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD conducts clinical trials around the world that involve the testing of new drugs or delivery methods to determine safety and effectiveness.
View all of PPD's news releases.
Oncology research presents a challenge to drug developers, with 60 percent of sites never enrolling a single patient. PPD uses a just-in-time methodology to jump-start study enrollment, augmenting traditional enrollment approaches to activate sites within 14 days of patient identification. This oncology enrollment enhancement solution leverages pre-identified patients from prequalified sites to provide first patient in, faster.
Find out how PPD can help you begin enrolling oncology patients within 14 days.
Learn how combining big data with innovative approaches connect the right sites and patients.
Contact us to learn more about our siteand patient offerings
We want to hear from you
Register in PPD's Database
RSS Twitter LinkedIn Facebook
© 2020 PPD, Inc. All Rights Reserved.